 
     RDKit          2D

 17 18  0  0  0  0  0  0  0  0999 V2000
   15.6014  -18.1299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6014  -18.9549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3158  -19.3674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0303  -18.9549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0303  -18.1299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3158  -17.7174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8869  -19.3674    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   17.8150  -19.2098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2999  -18.5424    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.8150  -17.8750    0.0000 B   0  0  0  0  0  0  0  0  0  0  0  0
   18.0690  -17.0931    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  1  6  1  0
  2  7  1  0
  4  8  1  0
  8  9  1  0
  9 10  1  0
  5 10  1  0
 10 11  1  0
  1 12  1  0
  3 13  1  0
  6 14  1  0
  8 15  1  0
  8 16  1  0
 11 17  1  0
M  END
>  <ALOGPS_LOGP>  (1) 
1.51

>  <ALOGPS_LOGS>  (1) 
-1.13

>  <ALOGPS_SOLUBILITY>  (1) 
1.13e+01 g/l

>  <DATABASE_ID>  (1) 
DB09041

>  <DATABASE_NAME>  (1) 
drugbank

>  <DRUGBANK_ID>  (1) 
DB09041

>  <DRUG_GROUPS>  (1) 
approved

>  <EXACT_MASS>  (1) 
152.044488

>  <FORMULA>  (1) 
C7H6BFO2

>  <GENERIC_NAME>  (1) 
Tavaborole

>  <INCHI_IDENTIFIER>  (1) 
InChI=1S/C7H6BFO2/c9-6-1-2-7-5(3-6)4-11-8(7)10/h1-3,10H,4H2

>  <INCHI_KEY>  (1) 
LFQDNHWZDQTITF-UHFFFAOYSA-N

>  <JCHEM_ACCEPTOR_COUNT>  (1) 
2

>  <JCHEM_ATOM_COUNT>  (1) 
17

>  <JCHEM_AVERAGE_POLARIZABILITY>  (1) 
14.207719106662456

>  <JCHEM_BIOAVAILABILITY>  (1) 
1

>  <JCHEM_DONOR_COUNT>  (1) 
1

>  <JCHEM_FORMAL_CHARGE>  (1) 
0

>  <JCHEM_GHOSE_FILTER>  (1) 
0

>  <JCHEM_IUPAC>  (1) 
5-fluoro-1,3-dihydro-2,1-benzoxaborol-1-ol

>  <JCHEM_LOGP>  (1) 
2.2371999999999996

>  <JCHEM_MDDR_LIKE_RULE>  (1) 
0

>  <JCHEM_NUMBER_OF_RINGS>  (1) 
2

>  <JCHEM_PHYSIOLOGICAL_CHARGE>  (1) 
0

>  <JCHEM_PKA>  (1) 
15.538352513154432

>  <JCHEM_PKA_STRONGEST_ACIDIC>  (1) 
8.914382285310808

>  <JCHEM_PKA_STRONGEST_BASIC>  (1) 
-4.835490669256251

>  <JCHEM_POLAR_SURFACE_AREA>  (1) 
29.46

>  <JCHEM_REFRACTIVITY>  (1) 
33.8568

>  <JCHEM_ROTATABLE_BOND_COUNT>  (1) 
0

>  <JCHEM_RULE_OF_FIVE>  (1) 
1

>  <JCHEM_TRADITIONAL_IUPAC>  (1) 
5-fluoro-3H-2,1-benzoxaborol-1-ol

>  <JCHEM_VEBER_RULE>  (1) 
1

>  <MOLECULAR_WEIGHT>  (1) 
151.93

>  <PRODUCTS>  (1) 
Kerydin

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
DB05058

>  <SMILES>  (1) 
OB1OCC2=CC(F)=CC=C12

>  <SYNONYMS>  (1) 
5-Fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole; 5-Fluoro-2,1-benzoxaborol-1(3H)-ol

$$$$
